RICHARD F POPS
CIK 1126490 · Director and CEO, Alkermes plc · last filed 2026-05-29
RICHARD F POPS is a Director and CEO, Alkermes plc who has filed 219 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for NBIX, was dated May 29, 2026. Across all open-market trades the lifetime net is −$140.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $72.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$72.68M
5
219
-$140.30M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Director | 37,798 | $159.82 | $6.04M | -$13.18M | 39 | 2026-05-29 |
| ALKS | Director and CEO, Alkermes plc | 1,377,740 | $48.37 | $66.64M | -$125.56M | 158 | 2026-03-04 |
| Epizyme, Inc. (EPZM) Delisted | Director | — | $1.47 | — | $0 | 8 | 2020-06-02 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 32,500 | $178.75 | $5.81M | -$1.55M | 8 | 2019-01-29 |
| EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | Director | — | — | — | $0 | 2 | 2008-06-02 |
Recent Filings
219 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2026-05-21 | NBIX | Exer (M) | +3,318 | $0 | EDGAR |
| 2026-05-18 | NBIX | Mixed | — | -$1.65M | EDGAR |
| 2026-05-15 | NBIX | Notice (144) | −15,000 | -$2.39M | EDGAR |
| 2026-03-04 | ALKS | Grant (A) | — | $0 | EDGAR |
| 2026-02-06 | ALKS | Mixed | +87,350 | -$2.09M | EDGAR |
| 2025-05-22 | NBIX | Mixed | +2,869 | $0 | EDGAR |
| 2025-02-20 | ALKS | Grant (A) | — | $0 | EDGAR |
| 2025-02-07 | ALKS | Mixed | +110,715 | -$2.51M | EDGAR |
| 2024-05-23 | NBIX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.